Insmed | Attività Correnti



Current Assets Cambiamento Data
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Cytokinetics USD 886.54M 69.51M 2025-06
DBV Technologies USD 29.15M 15.24M 2025-03
Dynavax Technologies USD 785.71M 30.26M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Insmed USD 2.08B 678.89M 2025-06
Novartis USD 29.7B 1.56B 2024-12
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Insmed Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.